Answers are grounded in this paper and cite their sources.
Despite improved therapies and preventive measures, death and disability from atherosclerotic vascular diseases is increasing in patients with autoimmune rheumatic diseases [1,2]. Premature atherosclerosis is likely to be a major underlying mechanism, yet the role of inflammation in ischemic strokes is not well understood [3]. The study of ischemic strokes in autoimmune rheumatic diseases could provide insight into the role played by immune cells in human stroke. Systemic lupus erythematosus (SLE) is often characterized as a prototype of autoimmune systemic diseases with a plethora of autoantibodies and organ-system involvement and various disease manifestations including nephritis, arthritis, pleurisy, pericarditis and vasculitis. Typical of SLE is the production of autoantibodies of different specificities and possibly related to disturbed apoptosis [4].
No takes yet. Share an insight, caveat, or question.
Jamal Mikdashi (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: